Silver Lining to Approval of Aducanumab? (White Paper)

White Paper

July 8, 2021

Download pdf

Silver Lining to Approval of Aducanumab?
by Cello Health BioConsulting’s Ginger Johnson, PhD
CEO

The accelerated and broad label approval of Biogen’s Alzheimer’s Disease (AD)drug aducanumab (Aduhelm) is controversial (to say the least) on many fronts,ranging from…More by clicking the Download pdf green button above.